Biohaven Ltd. reported financial results for first quarter ended March 31, 2026.
“On May 4, 2026, Biohaven Ltd. (the " Registrant ") issued a press release announcing its financial results for the first quarter ended March 31, 2026.”
Biohaven Ltd. — fact timeline
Source-grounded facts extracted from Biohaven Ltd.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Biohaven Ltd. reported financial results for first quarter ended March 31, 2024.
“Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the first quarter ended March 31, 2024, and provided a review of recent accomplishments and anticipated upcoming developments.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.